Jay Bhattacharya will have his work cut out for him if he wins confirmation as the next director of the U.S. NIH. Besides ...

Jazz Pharmaceuticals plc is buying Chimerix Inc. for $8.55 a share in cash, bringing the deal in at about $935 million. Jazz expands its cancer pipeline with the new acquisition’s lead candidate, ...